Project Grant R43DK136459

Award Date 9/1/23
Completion Date 9/9/24
Dollars Obligated $243K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $511,798 was awarded to Kilele Health Inc. on June 15, 2022 to develop continuous diagnostic monitoring platforms beyond glucose sensing. Unlike existing enzymatic glucose sensors, the company will utilize electrochemical aptamer sensors that can rapidly measure other molecules in the body with high specificity and sensitivity. The aim is to address limitations that have...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $990,990 project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Integrated Medical Sensors Inc., a minority-owned small disadvantaged business located in Irvine, CA. The project aims to optimize the manufacturing and quality framework for the company's miniaturized, integrated continuous glucose monitoring (CGM+) platform in preparation for larger human...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is providing $260,467 to Virginia Commonwealth University to develop ultrasensitive ion-selective optodes for self-testing of blood electrolytes. The goal is to create a handheld electrolyte monitor that can accurately measure blood levels of key ions like calcium, sodium,...
The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $450,000 Project Grant to the Texas A&M Engineering Experiment Station (Tees) to develop an injectable, grain-of-rice size glucose biosensor for continuous blood sugar monitoring. The key products or services to be provided under this 3-year grant include: Developing an injectable glucose biosensor comprised of a self-cleaning membrane and a near-infrared fluorescence...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will support the development and in-vivo testing of continuous electrochemical aptamer sensors for monitoring large analytes like insulin, inflammatory markers, and cardiac markers. The $360,320 award to the University of Cincinnati will fund a 2-year research project with the...
The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded Labsys LLC a $643,948 Project Grant to develop a wearable continuous drug monitoring device for opioid use disorders (CDM-MOUD). The goal is to create a low-cost, pain-free patch that can monitor medication levels in the interstitial fluid and provide real-time insights into the effectiveness of opioid use disorder treatment protocols. In Phase I, Labsys will engineer an...
The National Science Foundation awarded Integrated Medical Sensors Inc. a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel multi-analyte microsensor platform for continuous wireless monitoring applications. The grant aims to create a unique monolithic semiconductor platform capable of wirelessly monitoring multiple biochemical and physiological markers simultaneously in a sub-cubic millimeter footprint. This miniature,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the...
This $426,938 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health aims to develop self-calibrating ion-selective electrodes for at-home monitoring of blood electrolytes. The 2-year grant to Virginia Commonwealth University (VCU) will focus on designing portable, transportable, and mass-producible Ca2+ and K+ sensors that can provide accurate and...

A SENSOR PATCH FOR CONTINUOUS MONITORING OF SODIUM, GLUCOSE, AND KETONES CONCURRENTLY AND IN REAL-TIME - PRECISION NUTRITION IS AN EMERGING FIELD THAT RECOGNIZES HUMAN PHYSIOLOGICAL INDIVIDUALITY AND EXPLOITS IT TO PROCURE DIETARY RECOMMENDATIONS AND/OR INTERVENTIONS TO IMPROVE ONE'S HEALTH AND AID IN DISEASE PREVENTION, AND MANAGEMENT. METABOLIC PROFILING, WHICH INVOLVES QUANTIFYING BIOCHEMICAL CHANGES CAUSED BY DIETARY INTAKE, IS ESSENTIAL IN DECIPHERING THE COMPLEX CONNECTION BETWEEN DIET AND HEALTH STATUS, AND THEREFORE IS A CRITICAL TOOL TO ENABLE PRECISION NUTRITION. RECENTLY, WEARABLE BIOCHEMICAL SENSING DEVICES HAVE EMERGED AS CONVENIENT METHOD TO MONITOR THESE CHEMICAL CHANGES CONTINUOUSLY AND IN REAL-TIME, AND THEY ARE THUS POISED TO SIGNIFICANTLY PROGRESS THE FIELD. THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (NIDDK) SEEKS A SMART WEARABLE DEVICE FOR CONTINUOUS MONITORING OF CIRCULATING OR INTERSTITIAL NUTRIENTS, METABOLITES, OR HORMONES RELEVANT TO DIET AND NUTRITION. ACCORDINGLY, THE GOAL OF OUR PROPOSED PROJECT IS TO DEVELOP A WEARABLE DEVICE CAPABLE OF CONTINUOUSLY AND SIMULTANEOUSLY MEASURING, STORING, AND DISPLAYING INTERSTITIAL LEVELS OF MULTIPLE NUTRITIONALLY RELEVANT ANALYTES, INCLUDING SODIUM, GLUCOSE, AND KETONE, IN REAL TIME. SODIUM, GLUCOSE, AND KETONE BODIES ARE ALL ESSENTIAL INDICATORS FOR OVERALL HEALTH AND BODILY FUNCTION, AND THE CONTINUOUS AND SIMULTANEOUS MONITORING OF THEIR LEVELS WITHIN THE BODY COULD OFFER INVALUABLE CLINICALLY- AND NUTRITIONALLY- RELEVANT INFORMATION. TO DATE, NO FDA-CLEARED, COMMERCIALLY AVAILABLE DEVICE EXISTS FOR THE CONTINUOUS MONITORING OF MULTIPLE ANALYTES. IN THIS CONTEXT, ACTIOX LLC. HAS DEVELOPED AN INTEGRATED WIRELESSLY OPERATED WEARABLE SENSOR PLATFORM, BASED ON A BIOCOMPATIBLE ARRAY OF MICRONEEDLES, TO ENABLE PAIN-FREE CONTINUOUS ANALYSIS OF BIOCHEMICALS VIA INTERSTITIAL FLUID (ISF) JUST FEW HUNDRED MICRONS UNDER THE SKIN. THIS SBIR PHASE I PROJECT WILL LEVERAGE THIS INNOVATIVE TECHNOLOGY TO CREATE A MULTIPLEXED AND MULTIMODAL WEARABLE DEVICE THAT CAN MONITOR A PANEL OF PUTATIVE NUTRIENTS FOR ONE WEEK OF CONTINUOUS OPERATION. TO ACHIEVE THIS, READJUSTMENTS WILL BE PERFORMED AT SENSOR, ELECTRONICS, AND SMART PHONE APP LEVELS. AIM 1 CONSTITUTES IN-VITRO FEASIBILITY STUDIES TO FIND THE BEST CHEMICAL MODIFICATION STRATEGY WITH OPTIMAL SENSITIVITY, SELECTIVITY, REPRODUCIBILITY, AND EXTENDED 7-DAYS STABILITY WHILE MINIMIZING CROSS- REACTIVITY AMONG DIFFERENT SENSORS. AIM 2 WILL INVOLVE ELECTRONIC HARDWARE DESIGN AND DEVELOPMENT TO ENABLE CONCURRENT AMPEROMETRY AND POTENTIOMETRY MEASUREMENTS TO EXPAND THE DETECTION CAPABILITIES OF THE WEARABLE PLATFORM. UPON SUCCESSFUL COMPLETION OF PHASE I, PHASE II WILL FOCUS ON DEMONSTRATING THE UTILITY AND ESTABLISHING RELIABILITY OF THE MULTIPLEXED SENSOR VIA EXTENSIVE CLINICAL STUDIES IN HUMAN SUBJECTS. BY ENABLING REAL-TIME DATA COLLECTION OF SODIUM, GLUCOSE, AND KETONE CONCURRENTLY, THE PROPOSED WEARABLE DEVICE WILL SERVE VARIOUS ENVIRONMENTS, INCLUDING RESEARCH PROGRAMS, CLINICS, AND CONSUMER USE TO PROMOTE GENERAL HEALTH AND WELLNESS. THE FOUNDATIONAL INSIGHTS FROM THIS WORK WILL SET THE STAGE FOR ACCOMPLISHING OUR LONG-TERM VISION - A "LAB-UNDER- THE-SKIN," WHEREIN A WIDE PANEL OF NUTRIENTS AND METABOLITES CAN BE MONITORED USING A MINIATURIZED SKIN PATCH, THEREBY BECOMING A CORNERSTONE OF PRECISION NUTRITION.

Posted 8/11/23, 12:00 AM